Patents by Inventor David A. Katzenstein

David A. Katzenstein has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Publication number: 20070141565
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: February 6, 2007
    Publication date: June 21, 2007
    Inventors: Michael Kozal, Thomas Merigan, David Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Patent number: 7129041
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: October 31, 2006
    Assignee: The Board of Trustees of the Leland Stanford Junior University
    Inventors: Thomas C. Merigan, David A. Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acouired immunodeficiency syndrome
    Publication number: 20060110726
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: January 23, 2006
    Publication date: May 25, 2006
    Inventors: Michael Kozal, Thomas Merigan, David Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Publication number: 20030118986
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: December 16, 2002
    Publication date: June 26, 2003
    Inventors: Thomas C. Merigan, David A. Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Patent number: 6503705
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Grant
    Filed: February 13, 2001
    Date of Patent: January 7, 2003
    Assignee: Leland Stanford Junior University
    Inventors: Michael J. Kozal, Thomas C. Merigan, David A. Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Publication number: 20010018181
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Application
    Filed: February 13, 2001
    Publication date: August 30, 2001
    Inventors: Michael J. Kozal, Thomas C. Merigan, David A. Katzenstein, Mark Holodniy
  • Polymerase chain reaction assays for monitoring antiviral therapy and making therapeutic decisions in the treatment of acquired immunodeficiency syndrome
    Patent number: 5968730
    Abstract: The present invention relates to methods of monitoring, via polymerase chain reaction, the clinical progression of human immunodeficiency virus infection and its response to antiretroviral therapy. According to the invention, polymerase chain reaction assays may be used to predict immunological decline and to identify, at an early stage, patients whose infection has become resistant to a particular antiretroviral drug regimen.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: October 19, 1999
    Assignee: Leland Stanford Junior University
    Inventors: Thomas C. Merigan, David A. Katzenstein, Mark Holodniy